logo

For the Inventor, By the Inventor

Berlin, Germany

Herbert Wiesinger

USPTO Granted Patents = 13

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 93(Granted Patents)


Company Filing History:

goldMedal12 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 4 
 
Schering Aktiengellschaft
 patents

Years Active: 1995-2007

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7211680 - Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2007-05-01),
2. 7071344 - Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments (2006-07-04),
3. 6642218 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-11-04),
4. 6613920 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2003-09-02),
5. 6600058 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-07-29),
6. 6531459 - Vitamin D derivatives with phosphorus atoms in the side chains (2003-03-11),
7. 6376480 - Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2002-04-23),
8. 6372731 - Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments (2002-04-16),
9. 5700791 - Vitamin D derivatives modified in the 20-position and pharmaceutical (1997-12-23),
10. 5663157 - 22-en-25-oxa derivatives in the vitamin D series, process for their (1997-09-02),
11. 5585368 - 20-position modified pharmaceutically active vitamin D series compounds (1996-12-17),
12. 5583125 - 25-Carboxylic acid derivatives in the vitamin D series, process for (1996-12-10),
13. 5446035 - 20-methyl-substituted vitamin D derivatives (1995-08-29),

Title: The Innovative Contributions of Herbert Wiesinger

Introduction

Herbert Wiesinger is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of vitamin D derivatives. With a total of 13 patents to his name, Wiesinger's work has had a profound impact on the treatment of various diseases.

Latest Patents

Wiesinger's latest patents include innovative vitamin D derivatives with carbo- or heterocyclic substituents at C-25. These compounds are designed for the treatment of hyperproliferative diseases of the skin, tumor diseases, and various autoimmune conditions. His inventions also address issues such as secondary hyperparathyroidism, renal osteodystrophia, and diabetes mellitus type II. Another significant patent involves vitamin D derivatives with cyclopropyl rings in the lateral chains, which also have applications in producing medicaments.

Career Highlights

Throughout his career, Wiesinger has worked with prominent companies, including Schering Aktiengesellschaft. His expertise in medicinal chemistry has allowed him to develop groundbreaking solutions that address critical health issues. His innovative approach has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Wiesinger has collaborated with notable colleagues such as Andreas Steinmeyer and Gerald Kirsch. These partnerships have further enhanced his research and development efforts, leading to the successful creation of various medicinal compounds.

Conclusion

Herbert Wiesinger's contributions to the field of medicinal chemistry are invaluable. His innovative patents and collaborations have paved the way for advancements in the treatment of numerous diseases. His work continues to inspire future research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…